Patents by Inventor Magnus Gustafsson

Magnus Gustafsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11978957
    Abstract: An antenna arrangement having a stacked layered structure. The antenna arrangement includes a radiation layer including one or more radiation elements, and a distribution layer facing the radiation layer. The distribution layer is arranged to distribute a radio frequency signal to the one or more radiation elements. The distribution layer includes at least one distribution layer feed and a first electromagnetic bandgap, EBG, structure arranged to form at least one first waveguide intermediate the distribution layer and the radiation layer. The first EBG structure is also arranged to prevent electromagnetic propagation in a frequency band of operation from propagating from the at least one first waveguide in directions other than through the at least one distribution layer feed and the one or more radiation elements. The distribution layer includes a plurality of distribution modules and a positioning structure, the positioning structure is arranged to fix the distribution modules in position.
    Type: Grant
    Filed: January 12, 2021
    Date of Patent: May 7, 2024
    Assignee: GAPWAVES AB
    Inventors: Anders Wennergren, Magnus Gustafsson
  • Patent number: 11959954
    Abstract: A microstrip to waveguide transition comprising a waveguide module and a section of printed circuit board (PCB). The waveguide module comprises a waveguide aperture and a repetitive structure, the waveguide aperture being arranged extending through the module for attaching a waveguide to an external side of the module, the repetitive structure comprising a plurality of protruding elements arranged to surround the waveguide aperture on an internal side of the module and to define a passage into the waveguide aperture on the internal side, wherein the repetitive structure is configured to attenuate electromagnetic signal propagation in a frequency band past the repetitive structure while allowing propagation via the passage, the transition further comprising a PCB with a patch antenna connected to a transmission line and arranged to face the passage into the waveguide aperture.
    Type: Grant
    Filed: September 19, 2019
    Date of Patent: April 16, 2024
    Assignee: GAPWAVES AB
    Inventors: Hanna Karlsson, Esperanza Alfonso Alós, Magnus Gustafsson, Thomas Emanuelsson
  • Publication number: 20230344144
    Abstract: An antenna arrangement having a stacked layered structure. The antenna arrangement includes a radiation layer including one or more radiation elements, and a distribution layer facing the radiation layer. The distribution layer is arranged to distribute a radio frequency signal to the one or more radiation elements. The distribution layer includes at least one distribution layer feed and a first electromagnetic bandgap, EBG, structure arranged to form at least one first waveguide intermediate the distribution layer and the radiation layer. The first EBG structure is also arranged to prevent electromagnetic propagation in a frequency band of operation from propagating from the at least one first waveguide in directions other than through the at least one distribution layer feed and the one or more radiation elements. The distribution layer includes a plurality of distribution modules and a positioning structure, the positioning structure is arranged to fix the distribution modules in position.
    Type: Application
    Filed: January 12, 2021
    Publication date: October 26, 2023
    Applicant: GAPWAVES AB
    Inventors: Anders WENNERGREN, Magnus GUSTAFSSON
  • Publication number: 20230218835
    Abstract: A medicament delivery device comprising: a first component, and a second component arranged concentrically with the first component, wherein the second component is configured to move axially relative to the first component from a first position to a second position, wherein one of the first component and the second component has a radially extending flash, wherein the other one of the first component and the second component has a chamfer aligned with and facing the flash when the second component is in the first position, and wherein one of the chamfer and the flash is configured to contact and subsequently pass the other one of the chamfer and the flash when the second component is moved from the first position towards the second position to thereby facilitate movement of the second component.
    Type: Application
    Filed: June 15, 2021
    Publication date: July 13, 2023
    Inventors: Munib Baber, Magnus Gustafsson, Stefan Lööf
  • Publication number: 20210376439
    Abstract: A microstrip to waveguide transition comprising a waveguide module and a section of printed circuit board (PCB). The waveguide module comprises a waveguide aperture and a repetitive structure, the waveguide aperture being arranged extending through the module for attaching a waveguide to an external side of the module, the repetitive structure comprising a plurality of protruding elements arranged to surround the waveguide aperture on an internal side of the module and to define a passage into the waveguide aperture on the internal side, wherein the repetitive structure is configured to attenuate electromagnetic signal propagation in a frequency band past the repetitive structure while allowing propagation via the passage, the transition further comprising a PCB with a patch antenna connected to a transmission line and arranged to face the passage into the waveguide aperture.
    Type: Application
    Filed: September 19, 2019
    Publication date: December 2, 2021
    Inventors: Hanna KARLSSON, Esperanza ALFONSO ALÓS, Magnus GUSTAFSSON, Thomas EMANUELSSON
  • Patent number: 10774064
    Abstract: Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: September 15, 2020
    Assignee: Cadent Therapeutics, Inc.
    Inventors: Birgitte Langer Eriksen, Magnus Gustafsson, Charlotte Hougaard, Thomas Amos Jacobsen, Martin R. Jefson, Gregg F. Keaney, Jessica Klein, Janus Schreiber Larsen, John A. Lowe, III, John M. McCall, Dorte Strøbæk, Nadia Lybøl von Schoubye
  • Publication number: 20190218200
    Abstract: Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions which can be affected by potassium channel modulation. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.
    Type: Application
    Filed: June 2, 2017
    Publication date: July 18, 2019
    Inventors: Birgitte Langer Eriksen, Magnus Gustafsson, Charlotte Hougaard, Thomas Amos Jacobsen, Martin R. Jefson, Gregg F. Keaney, Jessica Klein, Janus Schreiber Larsen, John A. Lowe, III, John M. McCall, Dorte Strøbæk, Nadia Lybøl von Schoubye
  • Patent number: 10211507
    Abstract: A communication device for mounting to an infrastructure, the communication device being configured for communication with a remote communication device via a directive antenna main lobe, the communication device comprising a sensor module configured to measure a movement of the communication device relative to a reference orientation.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: February 19, 2019
    Assignee: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: Håkan Wennström, Magnus Gustafsson
  • Publication number: 20180115046
    Abstract: A communication device for mounting to an infrastructure, the communication device being configured for communication with a remote communication device via a directive antenna main lobe, the communication device comprising a sensor module configured to measure a movement of the communication device relative to a reference orientation.
    Type: Application
    Filed: April 22, 2016
    Publication date: April 26, 2018
    Inventors: Håkan Wennström, Magnus Gustafsson
  • Patent number: 9931329
    Abstract: Phenyl triazole derivative (specifically, 1-[6-[[5-(2-fluorophenyl)-3-methyl-triazol-4-yl]methoxy]-3-pyridyl]imidazole-4-carbonitrile or a pharmaceutically acceptable salt thereof), pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound is in particular considered useful for the treatment of central nervous system diseases and disorders which are responsive to modulation of GABAA receptors containing the ?5 subunit.
    Type: Grant
    Filed: November 16, 2015
    Date of Patent: April 3, 2018
    Assignee: SANIONA A/S
    Inventors: Janus Schreiber Larsen, Magnus Gustafsson, Carsten Jessen
  • Patent number: 9884848
    Abstract: This invention relates to a novel phenyl triazole derivative, pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound of the invention is in particular considered useful for the treatment of central nervous system diseases and disorders which are responsive to modulation of GABAA receptors containing the ?5 subunit.
    Type: Grant
    Filed: October 11, 2016
    Date of Patent: February 6, 2018
    Assignee: Saniona A/S
    Inventors: Janus Schreiber Larsen, Magnus Gustafsson, Carsten Jessen
  • Publication number: 20170114045
    Abstract: This invention relates to a novel phenyl triazole derivative, pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound of the invention is in particular considered useful for the treatment of central nervous system diseases and disorders which are responsive to modulation of GABAA receptors containing the ?5 subunit.
    Type: Application
    Filed: October 11, 2016
    Publication date: April 27, 2017
    Inventors: Janus Schreiber Larsen, Magnus Gustafsson, Carsten Jessen
  • Patent number: 9604361
    Abstract: A system for defining motions of a plurality of real robots cooperatively performing a show based on a description of the motions of the robots defined by animation software. The system includes at least one storage for storing a plurality of segments that describe the motions of the robots during the show, each segment includes a description of motions of one of the robots during a defined time period, and for storing a plurality of scenes, each scene specifying a plurality of segments to be executed simultaneously by the robots, and a playlist handler configured to handle creation of a playlist including a sequence of scenes and to amend the playlist according to user commands, and a user interface configured to display the playlist to a user, to allow the user to edit the playlist by amending the sequence of scenes, and to receive the user commands.
    Type: Grant
    Filed: February 5, 2014
    Date of Patent: March 28, 2017
    Assignee: ABB Schweiz AG
    Inventors: Magnus Gustafsson, Mark Ruth
  • Patent number: 9539395
    Abstract: Provided is a medicament delivery device comprising an axially elongated housing, a coaxially extending plunger rod mounted with in the housing for expelling successive doses of medicament and rotateable about the axis. The plunger rod can be axially displaced from a ready-to-use position for expelling a dose of medicament to a non-ready-to-use position axially spaced from said ready-to-use position along the axis, and from said non-ready-to use position to a subsequent ready-to-use position angularly spaced from said non-ready-to use position about the axis The device further comprises an indicator member displaceably mounted onto the housing between a first angular position indicative of the ready-to-use positions and a second angular position indicative of the non-ready-to use positions.
    Type: Grant
    Filed: October 7, 2011
    Date of Patent: January 10, 2017
    Assignee: SHL Group AB
    Inventors: Magnus Gustafsson, Stefan Lööf
  • Publication number: 20160311112
    Abstract: A system for defining motions of a plurality of real robots cooperatively performing a show based on a description of the motions of the robots defined by animation software. The system includes at least one storage for storing a plurality of segments that describe the motions of the robots during the show, each segment includes a description of motions of one of the robots during a defined time period, and for storing a plurality of scenes, each scene specifying a plurality of segments to be executed simultaneously by the robots, and a playlist handler configured to handle creation of a playlist including a sequence of scenes and to amend the playlist according to user commands, and a user interface configured to display the playlist to a user, to allow the user to edit the playlist by amending the sequence of scenes, and to receive the user commands.
    Type: Application
    Filed: February 5, 2014
    Publication date: October 27, 2016
    Inventors: Magnus Gustafsson, Mark Ruth
  • Patent number: 9475797
    Abstract: This invention relates to a novel phenyl triazole derivative, pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound of the invention is in particular considered useful for the treatment of central nervous system diseases and disorders which are responsive to modulation of GABAA receptors containing the ?5 subunit.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: October 25, 2016
    Assignee: Saniona A/S
    Inventors: Janus Schreiber Larsen, Magnus Gustafsson, Carsten Jessen
  • Publication number: 20160115155
    Abstract: This invention relates to a novel phenyl triazole derivative, pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound of the invention is in particular considered useful for the treatment of central nervous system diseases and disorders which are responsive to modulation of GABAA receptors containing the ?5 subunit.
    Type: Application
    Filed: June 25, 2013
    Publication date: April 28, 2016
    Applicant: SANIONA APS
    Inventors: Janus Schreiber LARSEN, Magnus GUSTAFSSON, Carsten JESSEN
  • Publication number: 20160067234
    Abstract: Phenyl triazole derivative (specifically, 1-[6-[[5-(2-fluorophenyl)-3-methyl-triazol-4-yl]methoxy]-3-pyridyl]imidazole-4-carbonitrile or a pharmaceutically acceptable salt thereof), pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound is in particular considered useful for the treatment of central nervous system diseases and disorders which are responsive to modulation of GABAA receptors containing the ?5 subunit.
    Type: Application
    Filed: November 16, 2015
    Publication date: March 10, 2016
    Applicant: SANIONA APS
    Inventors: Janus Schreiber LARSEN, Magnus GUSTAFSSON, Carsten JESSEN
  • Patent number: 9206160
    Abstract: This invention relates to a novel phenyl triazole derivative, pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound of the invention is in particular considered useful for the treatment of central nervous system diseases and disorders which are responsive to modulation of GABAA receptors containing the ?5 subunit.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: December 8, 2015
    Assignee: SANIONA APS
    Inventors: Janus Schreiber Larsen, Magnus Gustafsson, Carsten Jessen
  • Patent number: 9061981
    Abstract: Disclosed herein are novel di-aromatic compounds of the general formula (I). Also pharmaceutical compositions comprising the novel compounds and the use of the novel compounds in treatment and prevention of diseases and disorders related to estrogen receptors are disclosed. Furthermore, methods for treating and preventing diseases and disorders related to estrogen receptors by administration of the novel compounds are disclosed.
    Type: Grant
    Filed: August 1, 2012
    Date of Patent: June 23, 2015
    Assignee: Acadia Pharmaceuticals Inc.
    Inventors: Roger Olsson, Birgitte Lund, Magnus Gustafsson